1-3 of 3
Woodring E. Wright
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer

Free
Oliver Delgado, Kimberly G. Batten, James A. Richardson, Xian-Jin Xie, Adi F. Gazdar, Aadil A. Kaisani, Luc Girard, Carmen Behrens, Milind Suraokar, Gail Fasciani, Woodring E. Wright, Michael D. Story, Ignacio I. Wistuba, John D. Minna, Jerry W. Shay
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (6): 1610–1622.
https://doi.org/10.1158/1078-0432.CCR-13-2589
Published: 13 March 2014
View articletitled, Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer
Open the PDF for Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer in another window
Includes: Supplementary data
Journal Articles

A Targeted RNAi Screen of the Breast Cancer Genome Identifies KIF14 and TLN1 as Genes That Modulate Docetaxel Chemosensitivity in Triple-Negative Breast Cancer

Free
Stina Mui Singel, Crystal Cornelius, Kimberly Batten, Gail Fasciani, Woodring E. Wright, Lawrence Lum, Jerry W. Shay
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2061–2070.
https://doi.org/10.1158/1078-0432.CCR-13-0082
Published: 15 April 2013
View articletitled, A Targeted RNAi Screen of the Breast Cancer Genome Identifies KIF14 and TLN1 as Genes That Modulate Docetaxel Chemosensitivity in Triple-Negative Breast Cancer
Open the PDF for A Targeted RNAi Screen of the Breast Cancer Genome Identifies KIF14 and TLN1 as Genes That Modulate Docetaxel Chemosensitivity in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth

Free
Calin O. Marian, Steve K. Cho, Brian M. Mcellin, Elizabeth A. Maher, Kimmo J. Hatanpaa, Christopher J. Madden, Bruce E. Mickey, Woodring E. Wright, Jerry W. Shay, Robert M. Bachoo
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (1): 154–163.
https://doi.org/10.1158/1078-0432.CCR-09-2850
Published: 04 January 2010
View articletitled, The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
Open the PDF for The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth in another window
Includes: Supplementary data